SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
羊羊羊
Lv6
11
2420 积分
2023-07-15 加入
最近求助
最近应助
互助留言
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
10天前
已完结
Fragile Warriors: Navigating the Delicate Dance of Frailty and CAR-T cell Therapy for Relapsed/Refractory Multiple Myeloma
10天前
已完结
SAFETY AND EFFICACY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) IN OLDER PATIENTS: RESULTS FROM THE US LYMPHOMA CAR‐T CONSORTIUM
11天前
已完结
Approaches for vulnerable and frail older patients with diffuse large B-cell lymphomas
11天前
已完结
Supportive care for chimeric antigen receptor T-cell patients
12天前
已完结
Clash of the titans: axi-cel versus tisa-cel for advanced-stage DLBCL
13天前
已完结
The use of frailty assessments in treating older adults with aggressive lymphomas
14天前
已完结
Corrigendum
14天前
已完结
Application of Next-Generation Sequencing in Neurodegenerative Diseases: Opportunities and Challenges
14天前
已完结
Benefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B‐cell lymphoma after 2 or more lines of prior therapy
1个月前
已完结
没有进行任何应助
内容不全
11天前
点错标题 不符合【积分已退回】
7个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论